Professional Documents
Culture Documents
Biotechnology in India
Biotechnology in India
BIOTECHNOLOGY
The application of
Science & Technology
to living organisms
as well as parts,
products and models
thereof, to alter living
or non-living materials
for the production of
knowledge, goods
and services
India and Biotechnology Base
• Nascent stage
• Vast growth and opportunity
• Over 300 registered biotechnology companies,
out of which ~100 in are modern biotech sector
• Twelfth most successful biotechnology sector in
the world as measured by number of companies
(Ernst & Young)
• 96 enterprises exclusively as Biotech
companies, making India the third largest in
Asia [after Australia (228) and China (136)]
Biotechnology market
GROWTH 20%
RATE
2. QA/QC 17%
4. Process Development/Mfg
10%
6. Admin/Operations 7%
7. Information systems 5%
8. Regulatory Affairs 5%
9. Finance 4%
11. HR .5%
IMPLICATIONS FOR
OUTSOURCING –
Bio-manufacturing
Market Growth - Outsourcing
A recent survey by NIH found:
• Clinical trials
one of potential attraction for foreign big player
Advantage India : Clinical
Trials
• Large and heterogeneous population and
prevalence of wide spectrum of disease
conditions offer wide patient-resource.
• Low clinical trials cost in India .
• India has the 2nd highest number of
qualified doctors in the world.
• Patient enrollment rate for Phase III
studies could be up to 6 times faster in
India than in the Western countries.
Indian Biotechnology Industry
Number of biotech companies : 300
Global ranking in terms biotech companies : 11
Investment growth in last 5 years : 50 % per annum
Annual Turnover (Apr 06 – Mar 07) : US $ 1.27
Billion
Annual increase : 57 %
Percentage of global business (2006-07)
: 2.8% (2005-06) : 2.3%
(2004-05) : 1.6 %
(2003-04) : 1.5 %
(2002-03) : 1.2 %
Exports : 63 %
Major areas : Biopharma, Bioservices, Bioindustries,
Bioagriculture, Bioinformatics, Biosupplies
Biotechnology in India
Initiative in early 1980’s
Agencies - DST, CSIR, ICAR, ICMR, UGC
National Biotechnology Development Board – 1982
Department of Biotechnology – 1986
Strategy :
• Creation of Infrastructure
• Human Resources Development
• Promotion of R & D
• Technology Transfer
• Promotion of Industry
• Public Private Partnership
• Regulation
• International Co-operation
Indian Biotech Industry
Number of health-biotechnology patents
(Major developing countries) issued by US in 2006
India
South Korea
China
Brazil
Cuba
South Africa
Egypt
0 5 10 15 20 25 30 35
Manpower in
Biotechnology
TOTAL INVESTMENT IN
BIOTECH INDUSTRY
Core Areas of competence in
India
Core Areas of competence in India
•Capacity in bioprocess engineering
•Skills in gene manipulation of microbes and animal cells
•Capacity in downstream processing and isolation methods
•Skills in extraction and isolation of plants and animals products
•Competence in recombinant DNA technology of plants and
animals
•Excellence in traditional and molecular marker assisted breeding
of plants and animals
•Infrastructure in fabricating bio-reactors and processing
equipment
Indian Biotechnology: Strengths
Build culture
Build data base
Sharing of knowledge
Documentation
Promote for paper publication
Regular meeting
Biotech Products in Indian market
• r DNA Hep ‘B’ vaccine
• Recombinant streptokinase
• Erythropoietin
• α, β, γ – interferon
• Haemophilus influenzae B vaccine
• Human insulin
• Human Growth Hormone
• Human Interleukin
• Streptokinase
• Granulocyte Colony Stimulating Factor
• Follicle Stimulating Hormone
• Tissue Plasminogen Activator
My Experience in R&D
Microcarreier
3-D culture
S- adenocylmethionine
Selenium enriched yeast
Conclusion
• Growing market
• Strong base , proven quality
• Cheapest health facility
• Vaccines, diagnostics and therapeutics
• Biomedical devices, instruments and
sensors
• Bioartificial organs using tissue
engineering and stem cells
• Clinical trial and contract research
THANK YOU